Bathini Nagendra Babu

Bathini Nagendra Babu

Auto-generated profile, based on publicly available information

Bathini Nagendra Babu

Department of Fluoro-Agrochemicals CSIR-Indian Institute of Chemical Technology Hyderabad 500007, Telangana India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
PGParimala Devi Ganthala
Parimala Devi Ganthala
SASateesh Alavala
Sateesh Alavala
Naveen ChellaNaveen Chella
Naveen Chella
SASai Balaji Andugulapati
Sai Balaji Andugulapati
NBNagendra Babu Bathini
Nagendra Babu Bathini
RSRamakrishna Sistla
Ramakrishna Sistla

1 November 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ANAtulya Nagarsenkar
Atulya Nagarsenkar
LGLalita Guntuku
Lalita Guntuku
SGSravanthi Devi Guggilapu
Sravanthi Devi Guggilapu
DKDanthi Bai K.
Danthi Bai K.
SGSrinivasulu Gannoju
Srinivasulu Gannoju
NBNagendra Babu Bathini
Nagendra Babu Bathini

1 September 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SGSravanthi Devi Guggilapu
Sravanthi Devi Guggilapu
LGLalita Guntuku
Lalita Guntuku
STSrinivasa reddy Telukutla
Srinivasa reddy Telukutla
ANAtulya Nagarsenkar
Atulya Nagarsenkar
Dilep Kumar SigalapalliDilep Kumar Sigalapalli
Dilep Kumar Sigalapalli
NBNagendra Babu Bathini
Nagendra Babu Bathini

11 February 2015 in MedChemComm
Verified
Journal Article
Closed access
PDF file
SPSantosh Kumar Prajapti
Santosh Kumar Prajapti
SSShweta Shrivastava
Shweta Shrivastava
UBUmesh Bihade
Umesh Bihade
AGAjay Kumar Gupta
Ajay Kumar Gupta
VNVGM Naidu
VGM Naidu
BBBathini Nagendra Babu
Bathini Nagendra Babu
Novel Δ 2 -isoxazoline fused cyclopentane derivatives have been synthesized and evaluated for their antimicrobial and anticancer activities.

4 January 2016 in MedChemComm
Verified
Journal Article
Closed access
PDF file
ANAtulya Nagarsenkar
Atulya Nagarsenkar
SPSantosh Kumar Prajapti
Santosh Kumar Prajapti
SGSravanthi Devi Guggilapu
Sravanthi Devi Guggilapu
SBSwetha Birineni
Swetha Birineni
SKSudha Sravanti Kotapalli
Sudha Sravanti Kotapalli
BBBathini Nagendra Babu
Bathini Nagendra Babu
In continuation of our venture towards the synthesis of novel bioactive agents, two sets of triazole-linked glycoconjugates were synthesized from indole/oxindole (29 compounds) and were further characterized by IR (infrared spectroscopy), 1H NMR (nuclear magnetic resonance), 13C NMR and mass spectral analysis. The newly synthesized target compounds were evaluated for their preliminary in vitro anticancer activity against DU145 (prostate cancer), HeLa (cervical cancer), A549 (lung cancer) and MCF-7 (breast cancer) cell lines. In the sulforhodamine B (SRB) assay, the results indicated that compounds 5f (indole derivative) and E-9b (oxindole derivative) displayed remarkable cytotoxic activity against DU145 cells. Moreover, the colony formation assay (soft agar assay) revealed that compounds 5f and E-9b can inhibit the growth and proliferation of DU145 cells. The impact of the most active cytotoxic compounds 5f and E-9b on the cell cycle distribution was assessed in DU145 cells, which displayed a cell cycle arrest at the sub-G1 phase. Next, compounds 5f and E-9b were tested for caspase activation in DU145 cells, and the results specified that these compounds have the capability to induce apoptosis in cells through an intrinsic pathway leading to subsequent cell death. Further studies also confirmed that compounds 5f and E-9b act against the protein kinase B (Akt/PKB) pathway to inhibit the proliferation of cancer cells. Thus, compounds 5f and E-9b could be novel potential anticancer leads as the normal cell line NIH/3T3 (fibroblast) studies showed no significant cytotoxicity.

30 November 2015 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
SGSravanthi Devi Guggilapu
Sravanthi Devi Guggilapu
SPSantosh Kumar Prajapti
Santosh Kumar Prajapti
ANAtulya Nagarsenkar
Atulya Nagarsenkar
GLGuntuku Lalita
Guntuku Lalita
GVGanga Modi Naidu Vegi
Ganga Modi Naidu Vegi
BBBathini Nagendra Babu
Bathini Nagendra Babu
MoO2Cl2catalyzed Biginelli, Hantzsch reactions exploring spectroscopic and biological properties of novel compounds.